Similar articles

• Sequential nephron blockade versus sequential renin-angiotensin system blockade in resistant hypertension: a prospective, randomized, open blinded endpoint study.

  Bobrie G, Frank M, Azizi M, Peyrard S, Boutouyrie P, Chatellier G, Laurent S, Menard J, Plouin PF. Bobrie G, et al. J Hypertens. 2012 Aug;30(8):1656-64. doi: 10.1097/HJH.0b013e3283551e98. J Hypertens. 2012. PMID: 22728905 Clinical Trial.
• Greater efficacy of aldosterone blockade and diuretic reinforcement vs. dual renin-angiotensin blockade for left ventricular mass regression in patients with resistant hypertension.

  Azizi M, Perdrix L, Bobrie G, Frank M, Chatellier G, Ménard J, Plouin PF. Azizi M, et al. J Hypertens. 2014 Oct;32(10):2038-44; discussion 2044. doi: 10.1097/HJH.0000000000000280. J Hypertens. 2014. PMID: 24983187 Clinical Trial.
• Manipulation of the renin-angiotensin system.

  Givertz MM. Givertz MM. Circulation. 2001 Jul 31;104(5):E14-8. doi: 10.1161/hc3001.094733. Circulation. 2001. PMID: 11479264 Review. No abstract available.
• Inhibition of the renin-angiotensin-aldosterone system: is there room for dual blockade in the cardiorenal continuum?

  Volpe M, Danser AH, Menard J, Waeber B, Mueller DN, Maggioni AP, Ruilope LM. Volpe M, et al. J Hypertens. 2012 Apr;30(4):647-54. doi: 10.1097/HJH.0b013e32834f6e00. J Hypertens. 2012. PMID: 22278139 Review.
• Salt, the renin-angiotensin-aldosterone system and resistant hypertension.

  Shimosawa T. Shimosawa T. Hypertens Res. 2013 Aug;36(8):657-60. doi: 10.1038/hr.2013.69. Hypertens Res. 2013. PMID: 23912973 Review.